Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients

Abstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth fa...

Full description

Bibliographic Details
Main Authors: Emmanuelle Rouve, Karim Lakhal, Charlotte Salmon Gandonnière, Youenn Jouan, Laetitia Bodet-Contentin, Stephan Ehrmann
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Nephrology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12882-018-1091-2
id doaj-7f202586186d4b069bf7ac8b5085ca69
record_format Article
spelling doaj-7f202586186d4b069bf7ac8b5085ca692020-11-25T01:16:21ZengBMCBMC Nephrology1471-23692018-11-011911710.1186/s12882-018-1091-2Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patientsEmmanuelle Rouve0Karim Lakhal1Charlotte Salmon Gandonnière2Youenn Jouan3Laetitia Bodet-Contentin4Stephan Ehrmann5Medecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursReanimation chirurgicale polyvalente, service d’anesthesie-reanimation, Hôpital Laënnec, centre hospitalier universitaireMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursAbstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth factor binding protein 7 (IGFBP-7) were identified as highly sensitive and specific biomarkers for early detection of kidney aggression. The impact of contrast administration on those biomarkers has not been specifically evaluated but could provide clues about the toxicity of contrast media. This study aimed at measuring changes in TIMP-2 and IGFBP-7 urinary concentrations before and after a contrast-enhanced computed tomography in critically ill patients. Methods 77 patients were included in a prospective observational cohort study. Urinary [TIMP -2]·[IGFBP-7] was measured before, 6 and 24 h after contrast infusion. Urine output and serum creatinine were followed 3 days. Results Median [TIMP-2]·[IGFBP-7] was 0.06 [interquartile range 0.04;0.26], 0.07 [0.03;0.34] and 0.10 [0.04;0.37] (ng/mL)2/1000 respectively before, 6 and 24 h after contrast infusion. Individual changes from baseline were − 0.01 [− 0.11;0.11] and 0.00 [− 0.10;0.09] (ng/ml)2/1000 at 6 and 24 h. These changes were not higher among the patients increasing their Kidney Disease Improving Global Outcome (KDIGO) classification within 3 days after contrast infusion (n = 14 [18%] based on creatinine criterion only, n = 42 [55%] based on creatinine and urine output). Conclusions Changes in [TIMP-2]·[IGFBP-7] urinary concentration after contrast-enhanced computed tomography were insignificant, suggesting minimal kidney aggression by modern iodinated contrast media.http://link.springer.com/article/10.1186/s12882-018-1091-2Acute kidney injuryIodinated contrast mediaBiomarkersTIMP-2IGFBP-7Iohexol
collection DOAJ
language English
format Article
sources DOAJ
author Emmanuelle Rouve
Karim Lakhal
Charlotte Salmon Gandonnière
Youenn Jouan
Laetitia Bodet-Contentin
Stephan Ehrmann
spellingShingle Emmanuelle Rouve
Karim Lakhal
Charlotte Salmon Gandonnière
Youenn Jouan
Laetitia Bodet-Contentin
Stephan Ehrmann
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
BMC Nephrology
Acute kidney injury
Iodinated contrast media
Biomarkers
TIMP-2
IGFBP-7
Iohexol
author_facet Emmanuelle Rouve
Karim Lakhal
Charlotte Salmon Gandonnière
Youenn Jouan
Laetitia Bodet-Contentin
Stephan Ehrmann
author_sort Emmanuelle Rouve
title Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
title_short Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
title_full Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
title_fullStr Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
title_full_unstemmed Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
title_sort lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
publisher BMC
series BMC Nephrology
issn 1471-2369
publishDate 2018-11-01
description Abstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth factor binding protein 7 (IGFBP-7) were identified as highly sensitive and specific biomarkers for early detection of kidney aggression. The impact of contrast administration on those biomarkers has not been specifically evaluated but could provide clues about the toxicity of contrast media. This study aimed at measuring changes in TIMP-2 and IGFBP-7 urinary concentrations before and after a contrast-enhanced computed tomography in critically ill patients. Methods 77 patients were included in a prospective observational cohort study. Urinary [TIMP -2]·[IGFBP-7] was measured before, 6 and 24 h after contrast infusion. Urine output and serum creatinine were followed 3 days. Results Median [TIMP-2]·[IGFBP-7] was 0.06 [interquartile range 0.04;0.26], 0.07 [0.03;0.34] and 0.10 [0.04;0.37] (ng/mL)2/1000 respectively before, 6 and 24 h after contrast infusion. Individual changes from baseline were − 0.01 [− 0.11;0.11] and 0.00 [− 0.10;0.09] (ng/ml)2/1000 at 6 and 24 h. These changes were not higher among the patients increasing their Kidney Disease Improving Global Outcome (KDIGO) classification within 3 days after contrast infusion (n = 14 [18%] based on creatinine criterion only, n = 42 [55%] based on creatinine and urine output). Conclusions Changes in [TIMP-2]·[IGFBP-7] urinary concentration after contrast-enhanced computed tomography were insignificant, suggesting minimal kidney aggression by modern iodinated contrast media.
topic Acute kidney injury
Iodinated contrast media
Biomarkers
TIMP-2
IGFBP-7
Iohexol
url http://link.springer.com/article/10.1186/s12882-018-1091-2
work_keys_str_mv AT emmanuellerouve lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
AT karimlakhal lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
AT charlottesalmongandonniere lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
AT youennjouan lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
AT laetitiabodetcontentin lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
AT stephanehrmann lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients
_version_ 1725150073145262080